Sex difference in tolerability of adjuvant oxaliplatin-based chemotherapy for colorectal cancer and changes in diagnostic components of sarcopenia: A prospective study

被引：0
|
作者：
Nozawa, Hiroaki
Abe, Shinya
Abe, Kentaro
Yokota, Yumi
Yakabe, Mitsutaka
Akishita, Masahiro
Ishihara, Soichiro
机构：
[1] Univ Tokyo, Dept Surg Oncol, Tokyo, Japan
[2] Univ Tokyo, Dept Geriatr Med, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
基金：
日本学术振兴会;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15625
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Reinduction of oxaliplatin-based chemotherapy after exposure to oxaliplatin in adjuvant setting for colorectal cancer.
    Beom, Seung-Hoon
    Ahn, Joong Bae
    Shin, Sang Joon
    Jung, Minkyu
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [2] Oxaliplatin-based chemotherapy in the management of colorectal cancer
    Capdevila, Jaume
    Elez, Elena
    Peralta, Sergio
    Macarulla, Teresa
    Javier Ramos, Francisco
    Tabernero, Josep
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (08) : 1223 - 1236
  • [3] Sex hormones and sperm parameters after adjuvant oxaliplatin-based treatment for colorectal cancer
    Falk, P.
    Severin, M.
    Guren, M. Gronlie
    Osterlund, P.
    Hofsli, E.
    Giwercman, A.
    Eberhard, J.
    Sorbye, H.
    ANNALS OF ONCOLOGY, 2019, 30
  • [4] Sarcoidosis Associated with Oxaliplatin-Based Chemotherapy for Colorectal Cancer
    Choi, Ji Hoon
    Shin, Jung A.
    Park, Hye Kyeong
    Kim, Su Young
    Jung, Hoon
    Lee, Sung-Soon
    Lee, Hye Ran
    Koo, Hyeon-Kyoung
    CASE REPORTS IN ONCOLOGICAL MEDICINE, 2014, 2014
  • [5] Bevacizumab and oxaliplatin-based chemotherapy in metastatic colorectal cancer
    Beatty, Gregory L.
    Giantonio, Bruce J.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (05) : 683 - 688
  • [6] Splenomegaly in Colon Cancer During Adjuvant Oxaliplatin-based Chemotherapy
    Eren, Tulay
    Pasaoglu, Lale
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (03)
  • [7] phase II study of oxaliplatin-based regimen in relapsed colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy: INSPIRE study
    Kotaka, M.
    Ishibashi, K.
    Satake, H.
    Tsuji, Y.
    Kataoka, M.
    Nakamura, M.
    Nagata, N.
    Sakamoto, J.
    Oba, K.
    Mishima, H.
    ANNALS OF ONCOLOGY, 2020, 31 : S101 - S101
  • [8] Phase II study of an oxaliplatin-based regimen for relapsed colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy (INSPIRE study)
    Keiichiro Ishibashi
    Toru Aoyama
    Masahito Kotaka
    Hironaga Satake
    Yasushi Tsuji
    Masato Kataoka
    Masato Nakamura
    Naoki Nagata
    Junichi Sakamoto
    Koji Oba
    Hideyuki Mishima
    Cancer Chemotherapy and Pharmacology, 2021, 87 : 665 - 672
  • [9] Phase II study of an oxaliplatin-based regimen for relapsed colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy (INSPIRE study)
    Ishibashi, Keiichiro
    Aoyama, Toru
    Kotaka, Masahito
    Satake, Hironaga
    Tsuji, Yasushi
    Kataoka, Masato
    Nakamura, Masato
    Nagata, Naoki
    Sakamoto, Junichi
    Oba, Koji
    Mishima, Hideyuki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 87 (05) : 665 - 672
  • [10] Safety, tolerability, and efficacy of oxaliplatin-based adjuvant chemotherapy after curative resection of hepatic or extrahepatic metastases of Stage IV colorectal cancer
    Izuma Nakayama
    Mitsukuni Suenaga
    Takeru Wakatsuki
    Takashi Ichimura
    Masato Ozaka
    Daisuke Takahari
    Eiji Shinozaki
    Keisho Chin
    Masashi Ueno
    Nobuyuki Mizunuma
    Toshiharu Yamaguchi
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 133 - 139
12345